Ceftobiprole for the treatment of pneumonia: Aeuropean perspective

Keyphrases

• Adverse Events 16%
• Ceftazidime 16%
• Ceftobiprole 100%
• Ceftriaxone 16%
• Cephalosporins 33%
• Clinical Cure 33%
• Community-acquired Pneumonia 100%
• Cure Rate 33%
• Gastrointestinal Upset 16%
• Good Safety 16%
• Gram-negative Pathogens 16%
• Gram-positive Pathogens 16%
• Headache 16%
• In Vitro Activity 16%
• Linezolid 16%
• Mechanical Ventilation 16%
• Methicillin-resistant Staphylococcus Aureus 16%
• Monotherapy 16%
• Non-inferiority 16%
• Pneumonia 100%
• Safety Profile 16%
• Streptococcus Pneumoniae 16%
• Tolerability 16%
• Ventilator-associated Pneumonia 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 16%
• Ceftazidime 16%
• Ceftobiprole 100%
• Ceftriaxone 16%
• Cephalosporin 33%
• Community Acquired Pneumonia 50%
• Gastrointestinal Symptom 16%
• Headache 16%
• Hospital Acquired Pneumonia 50%
• Infectious Agent 33%
• Linezolid 16%
• Methicillin-Resistant Staphylococcus Aureus 16%
• Monotherapy 16%
• Penicillin Derivative 16%
• Streptococcus 16%
• Tolerability 16%
• Ventilator Associated Pneumonia 16%